Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Related Citations for PubMed (Select 15273130)

1.
2.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

3.
5.
6.

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.

Servais J, Hainaut M, Schmitz V, Maes P, Fransen K, Vaira D, Brichard B, Arendt V, Schneider F, Hemmer R, Schmit JC.

Pediatr Infect Dis J. 2002 Mar;21(3):214-20.

PMID:
12005085
7.

Primary drug resistance in antiretroviral-naïve injection drug users.

Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.

Int J Infect Dis. 2009 Sep;13(5):577-83. doi: 10.1016/j.ijid.2008.08.028. Epub 2008 Dec 25.

8.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

9.

Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities.

Sullivan PS, Buskin SE, Turner JH, Cheingsong R, Saekhou A, Kalish ML, Jones JL, Respess R, Kovacs A, Heneine W.

Int J STD AIDS. 2002 Aug;13(8):554-8.

PMID:
12194739
10.

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.

Medeiros MS, Arruda EA, Guerrant RL, Brown C, Hammarskjold ML, Rekosh D, Lima AA.

Braz J Infect Dis. 2007 Aug;11(4):390-4. Erratum in: Braz J Infect Dis. 2007 Oct;11(5):528-9.

11.

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?

Uy J, Brooks JT, Baker R, Hoffman M, Moorman A, Novak R; HOPS Investigators.

Antivir Ther. 2007;12(6):957-62.

PMID:
17926650
12.

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

de Mendoza C, del Romero J, Rodríguez C, Corral A, Soriano V.

AIDS. 2002 Sep 6;16(13):1830-2.

PMID:
12218398
13.
14.

HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.

Kagan R, Winters M, Merigan T, Heseltine P.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):1-9.

PMID:
15000693
15.

[Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province].

Yang K, Li JY, Bao ZY, Li HP, Li L, Zhuang DM, Wang Z, Li H.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 May;26(5):351-5. Chinese.

PMID:
16053762
16.

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

Zolopa AR, Lazzeroni LC, Rinehart A, Vezinet FB, Clavel F, Collier A, Conway B, Gulick RM, Holodniy M, Perno CF, Shafer RW, Richman DD, Wainberg MA, Kuritzkes DR.

Clin Infect Dis. 2005 Jul 1;41(1):92-9. Epub 2005 May 24.

17.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

18.

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.

Wirden M, Delaugerre C, Marcelin AG, Ktorza N, Ait Mohand H, Dominguez S, Schneider L, Ghosn J, Pauchard M, Costagliola D, Katlama C, Calvez V.

Antimicrob Agents Chemother. 2004 Feb;48(2):644-7.

19.

[Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].

Si XF, Huang HL, Wei M, Guan Q, Song YH, Ma PF, Quan Y, Xing H, Shao YM.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):308-11. Chinese.

PMID:
15650776
20.

Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.

Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suarez MD, Delgado E, Contreras G, Corral J, de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Basque Country.

J Clin Virol. 2005 Jul;33(3):224-9. Epub 2005 Jan 12.

PMID:
15911444
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk